Listed

Cal-Maine Foods Inc: Form 10-Q for the period ended Mar 1, 2025

Filed with the SEC on Apr 8, 2025 and accepted by EDGAR at Apr 8, 2025, 20:31 ET.

Share

Management's discussion and analysis

As filed, 2,463 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

DISCUSSION

AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

The following should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results

of Operations included in Part II Item 7 of the Company’s Annual Report on Form 10-K for its fiscal year ended June 1, 2024

(the “2024 Annual Report”), and the accompanying financial statements and notes included in Part II Item 8 of the 2024 Annual

Report and in

Part I Item 1

of this Quarterly Report on Form 10-Q (“Quarterly Report”).

This report contains numerous forward-looking statements within the meaning of Section 27A of the Securities Act of 1933

(the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”) relating to our shell egg

and egg products business, including estimated future production data, expected construction schedules, projected construction

costs, potential future supply of and demand for our products, potential future corn and soybean price trends, potential future

impact on our business of the resurgence in United States (“U.S.”) commercial table egg layer flocks of highly pathogenic avian

influenza (“HPAI”), potential future impact on our business of inflation and changing interest rates, potential future impact on

our business of new legislation, rules or policies, potential outcomes of legal proceedings, including loss contingency accruals

and factors that may result in changes in the amounts recorded, and other projected operating data, including anticipated results

of operations and financial condition. Such forward-looking statements are identified by the use of words such as “believes,”

“intends,” “expects,” “hopes,” “may,” “should,” “plans,” “projected,” “contemplates,” “anticipates,” or similar words. Actual

outcomes or results could differ materially from those projected in the forward-looking statements. The forward-looking

statements are based on management’s current intent, belief, expectations, estimates, and projections regarding the Company

and its industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and

other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ

materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in Part II

Market risk

As filed, 253 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in our exposure to market risk during the thirty-nine weeks ended March 1, 2025 from the

information provided in Part II Item 7A, Quantitative and Qualitative Disclosures About Market Risk in our 2024 Annual

Report.

Controls and procedures

As filed, 1,458 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

AND

PROCEDURES

Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed

by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time

periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include,

without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that

we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive

and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding

required disclosure. Based on an evaluation of our disclosure controls and procedures conducted by our Chief Executive Officer

and Chief Financial Officer, together with other financial officers, such officers concluded that our disclosure controls and

procedures were effective as of March 1, 2025 at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended March 1, 2025 that

has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 50,197 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

10-K for the year ended June 1, 2024, as well as those included in other reports we file from time to time with the SEC

(including our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K), (ii) the effect of the potential conversion of

all of the Company’s Class A Common Stock into Common Stock and resulting loss by the Company of controlled company

status under the rules of The Nasdaq Stock Market on the trading price of the Company’s Common Stock, the ability of the

Company to retain and hire key personnel and maintain relationships with its customers and suppliers, and on the Company’s

operating results and business generally, (iii) the impact on the trading price of the Company’s Common Stock as a result of

the sale or marketing, or potential sale or marketing, of a significant number of shares of the Company’s Common Stock held

by the family of our late founder, Fred R. Adams Jr., as part of their potential portfolio diversification efforts, (iv) the risks and

hazards inherent in the shell egg business (including disease, pests, weather conditions, and potential for product recall),

including but not limited to the current outbreak of HPAI affecting poultry in the U.S., Canada and other countries that was first

detected in commercial flocks in the U.S. in February 2022 and that first impacted our flocks in December 2023, (v) changes in

the demand for and market prices of shell eggs and feed costs, (vi) the impacts and potential future impacts of government,

customer and consumer reactions to recent high market prices for eggs, including but not limited to efforts to increase imports

of eggs and egg products, pressure to change long-standing pricing frameworks, lower consumer demand for eggs, and the

pending DOJ antitrust investigation, (vii) our ability to predict and meet demand for cage-free and other specialty eggs, (viii)

risks, changes, or obligations that could result from our recent or future acquisition of new flocks or businesses and risks or

changes that may cause conditions to completing a pending acquisition, such as the pending acquisition of Echo Lake Foods,

not to be met, (ix) risks relating to changes in inflation and interest rates, (x) our ability to retain existing customers, acquire

new customers and grow our product mix, (xi) adverse results in pending litigation and other legal matters, and (xii) global

instability, including as a result of the war in Ukraine, the conflicts in Israel and surrounding areas and attacks on shipping in

the Red Sea. Readers are cautioned not to place undue reliance on forward-looking statements because, while we believe the

assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-

looking statements will prove to be accurate. Further, forward-looking statements included herein are made only as of the

respective dates thereof, or if no date is stated, as of the date hereof. Except as otherwise required by law, we disclaim any

intent or obligation to update publicly these forward-looking statements, whether because of new information, future events, or

otherwise.

GENERAL

Cal-Maine Foods, Inc. (the “Company,” “we,” “us,” “our”) is primarily engaged in the production, grading, packaging,

marketing and distribution of fresh shell eggs. Our operations are fully integrated and we have one operating and reportable

segment. We are the largest producer and distributor of fresh shell eggs in the U.S. Our total flock of approximately 48.9

million layers and 12.3 million pullets and breeders is the largest in the U.S. We sell our shell eggs and egg products to a

diverse group of customers, including national and regional grocery store chains, club stores, companies servicing independent supermarkets in the U.S., foodservice distributors and egg product customers throughout the majority of the U.S. and aim to maintain efficient, state-of-the-art operations located close to our customers.

Our operating results are materially impacted by market prices for eggs and feed grains (corn and soybean meal), which are

highly volatile, independent of each other, and out of our control. Generally, higher market prices for eggs have a positive

impact on our financial results while higher market prices for feed grains have a negative impact on our financial results.

Although we use a variety of pricing frameworks with our customers for conventional and specialty eggs, we sell most of our

conventional shell eggs based on formulas that consider, in varying ways, independently quoted regional wholesale market

prices for shell eggs or formulas related to our costs of production which include the cost of corn and soybean meal. We sell the

majority of our specialty eggs at prices and terms negotiated directly with our customers. We do not sell eggs directly to

consumers or set the prices at which eggs are sold to consumers.

Retail sales of shell eggs historically have been highest during the fall and winter months and lowest during the summer

months. Prices for shell eggs fluctuate in response to seasonal demand factors and a natural increase in egg production during

the spring and early summer. Historically, shell egg prices tend to increase with the start of the school year and tend to be

highest prior to holiday periods, particularly Thanksgiving, Christmas and Easter. Consequently, and all other things being

equal, we would expect to experience lower selling prices, sales volumes and net income (and may incur net losses) in our first

and fourth fiscal quarters ending in August/September and May/June, respectively. Because of the seasonal and quarterly

fluctuations, comparisons of our sales and operating results between different quarters within a single fiscal year are not

necessarily meaningful comparisons.

We routinely fill our storage bins during harvest season when prices for feed ingredients are generally lower. To ensure

continued availability of feed ingredients, we may enter into contracts for future purchases of corn and soybean meal, and as

part of these contracts, we may lock-in the basis portion of our grain purchases several months in advance. Basis is the

difference between the local cash price for grain and the applicable futures price. A basis contract is a common transaction in

the grain market that allows us to lock-in a basis level for a specific delivery period and wait to set the futures price at a later

date. Furthermore, due to the more limited supply for organic ingredients, we may commit to purchase organic ingredients in

advance to help ensure supply. Ordinarily, we do not enter into long-term contracts beyond a year to purchase corn and soybean

meal or hedge against increases in the prices of corn and soybean meal. Corn and soybean meal are commodities and are

subject to volatile price changes due to weather, various supply and demand factors, transportation and storage costs,

speculators, agricultural, energy and trade policies in the U.S. and internationally, and global instability that could disrupt the

supply chain.

An important competitive advantage for Cal-Maine Foods is our ability to meet our customers’ evolving needs with a favorable

mix of branded and private-label products of conventional and specialty eggs, including cage-free, organic, brown, free-range,

pasture-raised and nutritionally-enhanced eggs as well as egg products.

HPAI

Outbreaks of HPAI have continued to occur in U.S. poultry flocks. In calendar year 2024, 40.2 million commercial layer hens

and pullets were depopulated due to HPAI, and in calendar year 2025, an additional 32.9 million commercial layer hens and

pullets have been depopulated through March. The United States Depart of Agriculture (the “USDA”) reported that the

estimated table-egg layer flock was approximately 285 million as of March 1, 2025, the lowest level since September 2015.

HPAI is currently widespread in the wild bird population worldwide. We remain dedicated to robust biosecurity programs

across our locations and have invested more than $70 million in biosecurity technology, equipment, procedures, and training

across our locations since the last major HPAI outbreak in 2015. However, no farm is immune from HPAI. For example, during

the third and fourth quarters of fiscal 2024, we experienced HPAI outbreaks within our facilities located in Kansas and Texas,

which are now fully operational. According to the U.S. Centers for Disease Control and Prevention (“CDC”), as of April 1,

2025, there were outbreaks in 996 herds of dairy cows in 17 states, and 70 human cases in the U.S., almost entirely among

poultry and dairy workers. However, in 2024, one of the human cases resulted in severe illness after the patient was exposed to

sick and dead birds in backyard flocks. The patient, who was reported to have underlying health conditions, died in January

2025. There have been no reported cases of person-to-person spread. According to the CDC, the human health risk to the U.S.

public from the HPAI virus is considered to be low. The extent of possible future outbreaks among U.S. commercial egg layer

flocks, with heightened risk during migration seasons, cannot be predicted. According to the USDA, HPAI cannot be

transmitted through safely handled and properly cooked eggs. There is no known risk related to HPAI associated with eggs that

are currently in the market and no eggs have been recalled. For additional information, see the 2024 Annual Report, Part II Item

7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – HPAI.”

We have taken proactive steps to help mitigate the tight egg supply situation across the country. Our efforts resulted in a 14%

increase in the average number of layer hens (reflecting both organic and inorganic expansion) and a 24% increase in total

chicks hatched during the third quarter of fiscal 2025 compared to the prior-year quarter. Our breeder flocks increased 33% as

of the end of the third fiscal quarter of 2025 compared to the end of the prior-year quarter. We also continue to invest in

expansion projects, including expected completion in calendar 2025 of approximately $60 million in ongoing expansion

projects within our current operations that are expected to add approximately 1.1 million cage-free layer hens and 250,000

pullets, and the successful conversion of a new egg processing facility and hatchery in Dexter, Missouri, projected to add

additional capacity of 1.2 million free range hens by calendar year end.

CAGE-FREE EGGS

Ten states have passed legislation or regulations mandating minimum space or cage-free requirements for egg production or

mandated the sale of only cage-free eggs and egg products in their states, with implementation of these laws ranging from

January 2022 to January 2030. These states represent approximately 27% of the U.S. total population according to the 2020

U.S. Census. California, Massachusetts, Colorado, Michigan, Oregon, Washington, and Nevada, which collectively represent

approximately 23% of the total estimated U.S. population, have cage-free legislation currently in effect. Due to the national egg

shortage caused by HPAI, Nevada temporarily suspended the cage-free egg mandate and other states are considering similar

actions.

A significant number of our customers have announced goals to either exclusively offer cage-free eggs or significantly increase

the volume of cage-free egg sales in the future, subject in most cases to availability of supply, affordability and consumer

demand, among other contingencies. Our customers typically do not commit to long-term purchases of specific quantities or

types of eggs with us, and as a result, it is difficult to accurately predict customer requirements for cage-free eggs. We are

focused on adjusting our cage-free production capacity with a goal of meeting the future needs of our customers in light of

changing state requirements and our customers’ goals. As always, we strive to offer a product mix that aligns with current and

anticipated customer purchase decisions. We are engaging with our customers to help them meet their announced goals and

needs. We have invested significant capital in recent years to acquire and construct cage-free facilities, and we expect our focus

for future expansion will continue to include cage-free facilities. Our volume of cage-free egg sales has continued to increase

and account for a larger share of our product mix. Cage-free egg revenue represented approximately 19.2% of our total shell

egg revenue for the third quarter of fiscal year 2025. At the same time, we understand the importance of our continued ability to

provide conventional eggs in order to provide our customers with a variety of egg choices and to address hunger in our

communities.

For additional information, see the 2024 Annual Report, Part I Item 1, “Business – Specialty Eggs,” “Business – Growth

Strategy” and “Business – Government Regulation,” and the first risk factor in Part I Item 1A, “Risk Factors” under the sub-

heading “Legal and Regulatory Risk Factors.”

ACQUISITIONS

Effective February 3, 2025, we acquired certain assets of Deal-Rite Foods, Inc. and certain of its affiliates (“Deal-Rite”). The

assets acquired included two feed mills, storage facilities, usable grain, vehicles, related equipment and a retail feed sales

business located in North Carolina. The acquired assets will produce and deliver feed to our nearby shell egg production

facilities.

During the first quarter of fiscal 2025, we acquired substantially all the commercial shell egg production, processing and egg

products breaking assets of ISE America, Inc. and certain of its affiliates (“ISE”). The assets acquired included commercial

shell egg production and processing facilities with a capacity at the time of acquisition of approximately 4.7 million laying

hens, including 1.0 million cage-free, and 1.2 million pullets, feed mills, approximately 4,000 acres of land, inventories and an

egg products breaking facility. The acquired assets also include an extensive customer distribution network across the Northeast

and Mid-Atlantic states, and production operations in Maryland, New Jersey, Delaware and South Carolina. These production

assets are our first in Maryland, New Jersey and Delaware. We believe this acquisition provides us with an opportunity to

significantly enhance our market reach in the Northeast and Mid-Atlantic states. See further discussion in

Note 2 – Acquisition

of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.

Effective on September 9, 2024, we completed a strategic investment with Crepini LLC, establishing a new egg products and

prepared foods venture. Crepini LLC, founded in 2007, grew its brand throughout the United States and Mexico featuring egg

wraps, protein pancakes, crepes, and wrap-ups, which are sold online and in over 3,500 retail stores. The new entity, located in

Hopewell Junction, New York, operates as Crepini Foods LLC (“Crepini”). We capitalized Crepini with approximately $6.75

million in cash to purchase additional equipment and other assets and fund working capital in exchange for a 51% interest in the

new venture. Crepini LLC contributed its existing assets and business in exchange for a 49% interest in the new venture.

In fiscal 2022, we announced a strategic investment in a new entity, MeadowCreek Food, LLC (“MeadowCreek”), which

became a majority-owned subsidiary. During March 2023, MeadowCreek began operations with a focus on being a leading

provider of hard-cooked eggs. During second quarter 2025, we acquired the remaining ownership interests in MeadowCreek

and it became a wholly-owned subsidiary.

In second quarter 2024, we acquired the assets of Fassio Egg Farms, Inc. (“Fassio”) related to its commercial shell egg

production and processing business. Fassio owned and operated commercial shell egg production and processing facilities with

a capacity at the time of acquisition of approximately 1.2 million laying hens, primarily cage-free, a feed mill, pullets, a

fertilizer production and composting operation and land located in Erda, Utah, outside Salt Lake City. This acquisition provided

us with an opportunity to expand our market presence in Utah and the western U.S., particularly for cage-free eggs. In fourth

quarter 2024, we acquired a broiler processing plant, hatchery and feed mill in Dexter, Missouri, which we repurposed for use

in shell egg production.

EXECUTIVE OVERVIEW

For the third quarter and first three quarters of fiscal 2025, we recorded a gross profit of $716.1 million and $1,319.4 million,

respectively, compared to $218.6 million and $355.1 million, respectively, for the same periods of fiscal 2024, primarily driven

by an increase in the net average selling price of shell eggs, primarily conventional egg prices, as well as an increase in total

dozens sold. Our results were also positively impacted by lower feed costs and our recent acquisitions discussed above,

partially offset by an increase in the volume and price of outside egg purchases.

Our net average selling price per dozen for the third quarter of fiscal 2025 was $4.060 compared to $2.247 in the prior-year

period. Conventional egg prices per dozen were $4.766 compared to $2.152 for the prior-year period, and specialty egg prices

per dozen were $2.784 compared to $2.415 for the prior-year period. Egg prices in the third quarter of fiscal 2025 were elevated

compared to the prior-year period primarily due to the resurgence of HPAI outbreaks, which decreased supply during the higher

seasonal demand cycle. According to the USDA, the monthly average size of the layer hen flock from December 2024 through

February (which most closely aligns with our third fiscal quarter) 2025 was approximately 302.7 million hens, which was a

decrease of 11.0 million layers, or 3.5%, compared to the same period in the prior year. The daily average price for the Urner

Barry southeast large index for the third quarter of fiscal 2025 increased 156% from the comparable period in the prior year.

Subsequent to third quarter fiscal 2025, the Urner Barry southeast large index decreased to $3.99 per dozen as of April 4, 2025

from a high of $8.69 per dozen as of February 28, 2025. For more information about historical shell egg prices, see Part I Item I

of our 2024 Annual Report.

Our dozens sold for the third quarter of fiscal 2025 increased 10.2% compared to the third quarter of fiscal 2025. Demand was

strong during the third fiscal quarter, which is typically a period of higher seasonal demand. We believe that other factors

positively impacting demand included severe weather events during the quarter, including the historic snowstorms in the

southern U.S. in January 2025, which prompted families to stock up on staples including eggs, and reported recommendations

of eggs as a good source of lean protein for individuals taking GLP-1 medications. In addition to strong consumer demand

during the quarter, we had an increase in production capacity with the acquisitions of the commercial shell egg production and

processing business of ISE during the first quarter of fiscal 2025.

Our farm production costs per dozen produced for the third quarter of fiscal 2025 decreased 5.7%, or $0.06 compared to the

prior year period, primarily due to lower feed costs. Feed costs per dozen produced decreased 9.6%, or $0.05, compared to the

third quarter of fiscal 2024, primarily due to lower feed ingredient prices. For information about historical corn and soybean

meal prices, see Part I Item I of our 2024 Annual Report. Our egg purchases and other cost of sales increased $163.8 million

quarter-over-quarter and $397.8 million comparing year-to-date periods, primarily due to higher shell egg prices as well as an

increase in dozens purchased to supply eggs for our customers, including those acquired in our ISE acquisition, during the

higher seasonal demand cycle while the nation experienced lower supply due to HPAI.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, certain items from our Condensed Consolidated Statements of Income

expressed as a percentage of net sales.

Thirteen Weeks Ended

Thirty-nine Weeks Ended

March 1, 2025

March 2, 2024

March 1, 2025

March 2, 2024

Net sales

100.0

100.0

100.0

100.0

Cost of sales

49.5

68.9

58.2

78.9

Gross profit

50.5

31.1

41.8

21.1

Selling, general and administrative

5.6

9.3

7.0

11.6

(Gain) loss on involuntary conversions

(1.4)

(0.6)

Operating income

44.9

23.2

34.8

10.1

Total other income, net

1.9

3.2

1.6

2.2

Income before income taxes

46.8

26.4

36.4

12.3

Income tax expense

10.9

5.5

8.7

2.6

Net income

35.9

20.9

27.7

9.7

Less: Loss attributable to noncontrolling

interest

(0.1)

Net income attributable to Cal-Maine

Foods, Inc.

35.9

20.9

27.7

9.8

NET SALES

Total net sales for the third quarter of fiscal 2025 were $1.4 billion compared to $703.1 million for the same period of fiscal

Shell egg sales represented 94.9% and 96.1% of total net sales for the third quarters of fiscal 2025 and 2024, respectively. The

Company’s shell egg offerings, for both branded and private-label products, include specialty and conventional shell eggs.

Specialty shell eggs include cage-free, organic, brown, free-range, pasture-raised and nutritionally enhanced eggs. Conventional

shell eggs sales represent all other shell egg sales not sold as specialty shell eggs. The Company’s egg products offerings

include liquid and frozen egg products and ready-to-eat products such as hard-cooked eggs, egg wraps, protein pancakes, crepes

and wrap-ups. Other sales represent feed sales, miscellaneous byproducts and resale products.

Total net sales for the thirty-nine weeks ended March 1, 2025 were $3.2 billion, compared to $1.7 billion for the comparable

period of fiscal 2024.

Shell egg sales represented 94.7% and 95.4% of total net sales for the thirty-nine weeks ended March 1, 2025 and March 2,

2024, respectively.

The table below presents net sales in key categories (in thousands, except percentage data):

Thirteen Weeks Ended

Thirty-nine Weeks Ended

March 1, 2025

March 2, 2024

% Change

March 1, 2025

March 2, 2024

% Change

Shell Eggs

1,345,382

675,912

99.0

2,990,756

1,608,377

85.9

Egg products

61,024

21,759

180.5

136,850

63,994

113.8

Other

11,279

5,405

108.7

30,621

13,283

130.5

Total net sales

1,417,685

703,076

101.6

3,158,227

1,685,654

87.4

The table below presents an analysis of our shell egg sales (in thousands, except percentage data):

Thirteen Weeks Ended

Thirty-nine Weeks Ended

March 1, 2025

March 2, 2024

March 1, 2025

March 2, 2024

Shell egg sales

Conventional

1,016,438

75.6

413,619

61.2

2,118,065

70.8

919,498

57.2

Specialty

328,944

24.4

262,293

38.8

872,691

29.2

688,879

42.8

Total shell egg sales

1,345,382

100.0

675,912

100.0

2,990,756

100.0

1,608,377

100.0

Dozens sold

Conventional

213,247

64.3

192,182

63.9

622,833

64.1

566,174

65.7

Specialty

118,148

35.7

108,597

36.1

348,385

35.9

295,904

34.3

Total dozens sold

331,395

100.0

300,779

100.0

971,218

100.0

862,078

100.0

Net average selling price per dozen

Conventional

4.766

2.152

3.401

1.624

Specialty

2.784

2.415

2.505

2.328

All shell eggs

4.060

2.247

3.079

1.866

Shell egg sales

Third Quarter – Fiscal 2025 vs. Fiscal 2024

In the third quarter of fiscal 2025, conventional egg sales increased $602.8 million, or 145.7%, compared to the third

quarter of fiscal 2024, primarily due to a 121.5% increase in the prices for conventional eggs, which resulted in a

$557.4 million increase in net sales, and a 11.0% increase in the volume of conventional eggs sold, which resulted in a

$45.3 million increase in net sales. Results for the third quarter of 2025 were positively impacted by our acquisition of

ISE during the current fiscal year as well as the resumption of full operations at our facility in Chase, KS, which was

shut down in the prior year quarter due to an HPAI outbreak.

Specialty egg sales increased $66.7 million, or 25.4%, in the third quarter of fiscal 2025 compared to the third quarter

of fiscal 2024, primarily due to a 15.3% increase in prices for specialty eggs, which resulted in a $43.6 million

increase in net sales and a 8.8% increase in the volume of specialty eggs sold, which resulted in a $23.1 million

increase in net sales.

See “Executive Overview” above for additional discussion.

Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024

  • For the thirty-nine weeks ended March 1, 2025, conventional egg sales increased $1.2 billion, or 130.4%, compared to

the same period of fiscal 2024, primarily due to the increase in the prices for conventional shell eggs. Prices for

conventional eggs increased 109.4%, which resulted in a $1.1 billion increase in net sales. A 10.0% increase in the

volume of conventional eggs sold resulted in a $92.0 million increase in net sales.

Specialty egg sales increased $183.8 million, or 26.7%, for the thirty-nine weeks ended March 1, 2025 compared to

the same period in fiscal 2024, primarily due to a 17.7% increase in the volume of specialty eggs sold, which resulted

in a $122.2 million increase in net sales and a 7.6% increase in prices for specialty eggs, which resulted in a $61.7

million increase in net sales.

Egg products sales

Third Quarter – Fiscal 2025 vs. Fiscal 2024

Egg products sales increased $39.3 million, or 180.5%, for the third quarter of fiscal 2025 compared to the same

period of fiscal 2024, primarily due to a 200.5% increase in sales of liquid eggs, which had a $22.0 million positive

impact on net sales, and a 46.1% increase in liquid eggs pounds sold, which resulted in a $6.6 million increase in net

sales. Results for the third quarter of 2025 were positively impacted by our recent acquisition of ISE, which included a

breaking facility.

Sales from hard-cooked eggs increased $6.6 million or 181.5% in the third quarter of fiscal 2025 compared to fiscal

2024 as more processing capabilities are coming online from our investments in MeadowCreek.

Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024

  • Egg products sales increased $72.9 million, or 113.8%, primarily due to a 118.0% increase in sales of liquid eggs,

which had a $31.6 million positive impact on net sales, and a 42.0% increase in liquid eggs pounds sold, which

resulted in a $17.4 million increase in net sales.

Sales from hard-cooked eggs increased $18.7 million, or 188.6%, in the first three quarters of fiscal 2025 compared to

the same period in fiscal 2024, primarily for the reasons described above.

Other

Other sales increased compared to the prior year periods primarily due to higher feed sales related to our ISE

acquisition.

COST OF SALES

Cost of sales consists of costs directly related to producing, processing and packing shell eggs, purchases of shell eggs from

outside sources, processing and packing of egg products and other non-egg costs. Farm production costs are those costs

incurred at the egg production facility, including feed, facility (including labor), hen amortization and other related farm

production costs.

The following table presents the key variables affecting our cost of sales (in thousands, except cost per dozen data):

Thirteen Weeks Ended

Thirty-nine Weeks Ended

March 1, 2025

March 2, 2024

Change

March 1, 2025

March 2, 2024

Change

Cost of sales

Farm production

266,056

248,650

7.0

766,003

760,525

0.7

Processing, packaging,

and warehouse

101,631

86,423

17.6

292,165

253,096

15.4

Egg purchases and other

cost of sales

291,703

127,925

128.0

658,182

260,375

152.8

Egg products

42,180

21,506

96.1

122,502

56,523

116.7

Total cost of sales

701,570

484,504

44.8

1,838,852

1,330,519

38.2

Farm production costs (per

dozen produced)

Feed

0.492

0.544

(9.6)

0.489

0.564

(13.3)

Other

0.418

0.421

(0.7)

0.420

0.431

(2.6)

Total farm production cost

0.910

0.965

(5.7)

0.909

0.995

(8.6)

Outside egg purchases

(average cost per dozen)

5.10

2.44

109.0

3.69

2.09

76.6

Dozens produced

293,087

259,527

12.9

847,962

774,984

9.4

Percent produced to sold

88.4%

86.3%

2.4

87.3%

89.9%

(2.9)

Farm Production

Third Quarter – Fiscal 2025 vs. Fiscal 2024

Feed costs per dozen produced decreased 9.6% in the third quarter of fiscal 2025 compared to the third quarter of

fiscal 2024. This decrease was primarily due to lower prices for soybean meal, one of our primary feed ingredients.

The decrease in feed cost per dozen resulted in a decrease in cost of sales of $15.2 million for the third quarter of fiscal

2025 compared to the prior period quarter.

For the third quarter of fiscal 2025, the average Chicago Board of Trade (“CBOT”) daily market price was $4.68 per

bushel of corn and $298 per ton of soybean meal, representing an increase of 3.8% and a decrease of 19.3%,

respectively, as compared to the average CBOT daily market prices for the third quarter of fiscal 2024.

Other farm production costs decreased primarily due to lower flock amortization. Feed costs reached their peak in the

second quarter of fiscal 2023 and have since trended downward. Lower costs result in lower capitalized values of the

flocks during the grow out phase, which reduced amortization cost over time.

Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024

Feed costs per dozen produced decreased 13.3% in the thirty-nine weeks ended March 1, 2025 compared to the same

period of fiscal 2024, primarily due to lower feed ingredient prices. The decrease in feed cost per dozen resulted in a

decrease in cost of sales of $63.6 million compared to the prior year period.

For the year-to-date period, the average CBOT daily market price was $4.29 per bushel of corn and $316 per ton of

soybean meal, representing decreases of 11.8% and 21.5%, respectively, compared to the average CBOT daily market

prices for the comparable period in the prior year.

Other farm production costs decreased due to lower flock amortization, for the reasons described above.

Current indications for corn and soybean project a favorable stocks-to-use ratio near the levels prevailing today for the

remainder of fiscal 2025; however, as long as outside factors remain uncertain (including weather patterns and global supply

chain disruptions), volatility could remain.

Processing, packaging, and warehouse

Third Quarter – Fiscal 2025 vs. Fiscal 2024

Processing, packaging, and warehouse costs increased 17.6% compared to the third quarter of fiscal 2024 due to a

13.5% increase in the volume of processed dozens as well as an increase in costs of packaging materials.

Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024

Processing, packaging, and warehouse costs increased 15.4% compared to the first three quarters of fiscal 2025,

primarily due a 10.3% increase in the volume of processed dozens as well as an increase in costs of packaging

materials.

Egg purchases and other cost of sales

Third Quarter – Fiscal 2025 vs. Fiscal 2024

Costs in this category increased primarily due to higher shell egg prices as the average cost per dozen of outside egg

purchases increased 109.0% compared to third quarter of fiscal 2024, as well as due to an increase of 8.8% in dozens

purchased. Dozens purchased increased due to purchasing more eggs to supply our customers during the higher

seasonal demand cycle while the nation experienced lower supply due to HPAI.

Thirty-nine weeks – Fiscal 2025 vs. Fiscal 2024

Costs in this category increased primarily due to higher shell egg prices as the average cost per dozen of outside egg

purchases increased 76.6% compared to fiscal 2024, as well as an increase of 46.2% in dozens purchased, primarily

for the reasons described above.

GROSS PROFIT

Gross profit for the thirteen weeks ended March 1, 2025 was $716.1 million compared to $218.6 million for the same period of

2024. Gross profit for the thirty-nine weeks ended March 1, 2025 was $1.3 billion compared to $355.1 million for the same

period of 2024. The increases were primarily due to higher net average selling prices, particularly for conventional eggs, and higher volumes, as well as lower feed ingredient prices, partially offset by the increase in volume and price of outside egg purchases.

SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES

Selling, general, and administrative (“SGA”) expenses include costs of delivery, marketing, and other general and

administrative expenses. Delivery expense includes contract trucking expense and all costs to maintain and operate our fleet of

trucks to deliver products to customers including the related payroll expenses. Marketing expense includes franchise fees that

are submitted to Eggland’s Best, Inc. (“EB”) to support the EB brand, brokerage and commission fees, and other general

marketing expenses such as payroll expenses for our in-house sales team. Other general and administrative expenses include

corporate payroll related expenses and other general corporate overhead costs. The following table presents an analysis of our

SGA expenses (in thousands):

Thirteen Weeks Ended

March 1, 2025

March 2, 2024

$ Change

% Change

Delivery expense

23,476

18,832

4,644

24.7

Marketing expense

11,240

14,149

(2,909)

(20.6)

Other general and administrative

expenses

45,251

33,039

12,212

37.0

Total

79,967

66,020

13,947

21.1

Third Quarter – Fiscal 2025 vs. Fiscal 2024

Delivery expense

The increased delivery expense is primarily due to an increase in our sales volumes of egg and egg products compared

to the prior year period. Contract trucking expenses increased in connection with our acquisition of ISE and our

facility in Chase, KS being fully operational in the current fiscal quarter. We also obtained some new business and

additional shipping routes in order to meet our customers’ needs at their locations.

Marketing expense

The decrease in marketing expense is primarily due to a decrease in franchise fees. The higher prices for conventional

eggs compared to specialty eggs diminished the need to promote specialty eggs; as a result EB temporarily reduced the

related franchise fees for certain specialty egg brands to encourage continued production of these branded eggs.

Other general and administrative expense

The increase in other general and administrative expense is primarily due both to an increase in the accrual for

anticipated employee bonuses and to the increased adjustment to the fair value of contingent consideration associated

with the Fassio acquisition. See further discussion in

Note 4 – Fair Value Measurements

of the Notes to Condensed

Consolidated Financial Statements included in this Quarterly Report.

Thirty-nine Weeks Ended

March 1, 2025

March 2, 2024

$ Change

% Change

Delivery expense

68,206

54,229

13,977

25.8

Marketing expense

40,666

38,809

1,857

4.8

Litigation loss contingency accrual

19,648

(19,648)

(100.0)

Other general and administrative

expenses

110,660

82,158

28,502

34.7

Total

219,532

194,844

24,688

12.7

Thirty-six weeks – Fiscal 2025 vs. Fiscal 2024

Delivery expense

The increased delivery expense is primarily due to the reasons described above

Marketing expense

The increase in marketing expense is primarily due to an increase in franchise fees in the first half of fiscal 2025 as

specialty egg sales increased, partially offset by the reduction in fees in the third quarter of fiscal 2025 described

above.

Litigation loss contingency accrual

In the second quarter of fiscal 2024, we accrued a $19.6 million loss contingency relating to a jury decision returned in

pending anti-trust litigation. See further discussion in

Note 10 - Commitments and Contingencies

of the Notes to

Condensed Consolidated Financial Statements included in this Quarterly Report.

Other general and administrative expense

The increase in other general and administrative expense is primarily for the reasons described above, as well as costs

associated with the acquisition of ISE assets that occurred during the first quarter of fiscal 2025.

GAIN ON INVOLUNTARY CONVERSION

In the third quarter of fiscal 2024, we recorded a gain of $9.9 million due to recoveries under indemnity and insurance programs

that exceeded the amortized book value of the covered assets and our direct costs, primarily related to the HPAI outbreak at our

Kansas facility.

OPERATING INCOME

For the third quarter of fiscal 2025, we recorded operating income of $635.7 million compared to operating income of $162.8

million for the same period of fiscal 2024.

For the thirty-nine weeks ended March 1, 2025, we recorded operating income of $1.1 billion compared to operating income of

$170.3 million for the same period of fiscal 2024.

OTHER INCOME (EXPENSE)

Total other income (expense) consists of items not directly charged or related to operations, such as interest income and

expense, equity in income or loss of unconsolidated entities, and patronage dividends, among other items. Patronage dividends

are paid to us from our membership in the EB cooperative.

For the third quarter of fiscal 2025, we earned $12.8 million of interest income compared to $7.8 million for the same period of

fiscal 2024, primarily due to higher average cash and cash equivalents and investment securities available-for-sale balances and

yields. The Company recorded interest expense of $146 thousand and $247 thousand for the third quarters ended March 1, 2025

and March 2, 2024, respectively.

For the thirty-nine weeks ended March 1, 2025, we earned $32.6 million of interest income compared to $22.4 million for the

same period of fiscal 2024, primarily due to higher average cash and cash equivalents and investment securities available-for-

sale balances and yields. The Company recorded interest expense of $457 thousand and $523 thousand for the thirty-nine weeks

ended March 1, 2025 and March 2, 2024, respectively.

INCOME TAXES

For the third quarter of fiscal 2025, our pre-tax income was $663.0 million, compared to $185.2 million for the third quarter of

fiscal 2024. Income tax expense of $154.9 million was recorded for third quarter 2025 with an effective tax rate of 23.4%. This

includes the discrete tax benefit of $5.7 million associated with the fiscal 2024 provision-to-return adjustments. Excluding the

discrete tax benefit, income tax expense was $160.8 million for the third quarter of fiscal 2025 with an adjusted effective tax

rate of 24.2%. For the third quarter 2024, income tax expense was $38.8 million with an effective tax rate of 21.0%. This

includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments. Excluding the

discrete tax benefit, income tax expense was $45.2 million with an adjusted effective tax rate of 24.4%.

For the thirty-nine weeks ended March 1, 2025, pre-tax income was $1.1 billion, compared to $208.0 million for the same

period of fiscal 2024. Income tax expense of $273.8 million was recorded for the thirty-nine weeks ended March 1, 2025 with

an effective tax rate of 23.8%. This includes the discrete tax benefit of $5.7 million associated with the fiscal 2024 provision-to-

return adjustments. Excluding the discrete tax benefit, income tax expense was $279.5 million with an adjusted effective tax

rate of 24.3%. For the same period of fiscal 2024, income tax expense was $44.7 million with an effective tax rate of 21.5%.

This includes the discrete tax benefit of $6.4 million associated with the fiscal 2023 provision-to-return adjustments. Excluding

the discrete tax benefit, income tax expense was $51.0 million with an adjusted effective tax rate of 24.5%.

Items causing our effective tax rate to differ from the federal statutory income tax rate of 21% are state income taxes, certain

federal tax credits and certain items included in income or loss for financial reporting purposes that are not included in taxable

income or loss for income tax purposes, including tax exempt interest income, certain nondeductible expenses, and net income

or loss attributable to noncontrolling interest.

NET INCOME ATTRIBUTABLE TO CAL-MAINE FOODS, INC.

Net income attributable to Cal-Maine Foods, Inc. for the third quarter ended March 1, 2025 was $508.5 million, or $10.42 per

basic and $10.38 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $146.7 million, or

$3.01 per basic and $3.00 per diluted common share, for the same period of fiscal 2024.

Net income attributable to Cal-Maine Foods, Inc. for the thirty-nine weeks ended March 1, 2025, was $877.6 million, or $17.99

per basic and $17.92 per diluted common share, compared to net income attributable to Cal-Maine Foods, Inc. of $164.6

million or $3.38 per basic and $3.37 per diluted common share, for the same period of fiscal 2024.

LIQUIDITY AND CAPITAL RESOURCES

Working Capital and Current Ratio

Our working capital was $1.5 billion at March 1, 2025 compared to $1.0 billion at June 1, 2024. The calculation of working

capital is defined as current assets less current liabilities. Our current ratio was 3.9 at March 1, 2025 compared to 5.5 at June 1,

2024. The decrease in our current ratio is primarily due to the increase in both income taxes and trade payables. The current

ratio is calculated by dividing current assets by current liabilities.

Cash Flows from Operating Activities

For the thirty-nine weeks ended March 1, 2025, $811.7 million in net cash was provided by operating activities, compared to

$237.6 million provided by operating activities for the comparable period in fiscal 2024. The increase in cash flow from

operating activities resulted primarily from higher net average selling prices per dozen, particularly for conventional eggs,

increased volume of sales and a decrease in feed ingredient costs compared to the prior-year period, partially offset by the

increase in volume and price of outside egg purchases.

Cash Flows from Investing Activities

For the thirty-nine weeks ended March 1, 2025, $385.1 million was used in investing activities, primarily due to the acquisition

of assets of ISE, and purchases of property, plant and equipment compared to $118.4 million used in investing activities in the

same period of fiscal 2024, primarily due to purchases of investment securities. Purchases of investment securities were $813.1

million during the thirty-nine weeks ended March 1, 2025 and sales and maturities of investment securities were $654.4 million

during the period. Sales and maturities of investment securities were $273.9 million in the prior year period while purchases of

investment securities were $243.5 million during the period. The increase in sales and maturities of investment securities is

primarily due to the maturities of short-term investments during the first three quarters of fiscal 2025. Cash paid for business

acquisitions was $116.2 million in the thirty-nine weeks ended March 1, 2025, primarily related to the ISE acquisition, and

$53.7 million in the prior year period, related to the Fassio acquisition. Purchases of property, plant and equipment were $115.4

million and $96.0 million in the first three quarters of fiscal 2025 and 2024, respectively, primarily reflecting progress on our

construction projects.

Cash Flows from Financing Activities

We paid dividends of $160.8 million for the thirty-nine weeks ended March 1, 2025 compared to $43.0 million in the same

prior-year period.

As of March 1, 2025, cash increased $259.4 million since June 1, 2024, compared to $74.3 million during the same period of

fiscal 2024. The increase is primarily due to the increase in net sales during fiscal 2025.

Credit Facility

On November 15, 2021, we entered into a credit agreement that provides for a senior secured revolving credit facility (the

“Credit Facility”), in an initial aggregate principal amount of up to $250 million with a five-year term. As of March 1, 2025, no

amounts were borrowed under the Credit Facility and we had $4.7 million in outstanding standby letters of credit issued under

our Credit Facility for the benefit of certain insurance companies. On March 25, 2025, we entered into the Second Amendment

to the Credit Facility. Refer to Part I. Item I, Notes to Consolidated Financial Statements,

Note 11 – Subsequent Events

included in this report, Exhibit 10.2 to this report and Part II Item 8, Notes to Consolidated Financial Statements and

Supplementary Data, Note 10 - Credit Facility included in our 2024 Annual Report for further information regarding our long-

term debt.

Share Repurchase Program

On February 25, 2025, the Board of Directors approved a new $500 million share repurchase program. The share repurchase

program authorizes the Company, in management’s discretion, to repurchase Common Stock from time to time for an aggregate

purchase price up to $500 million (exclusive of any fees, taxes, commissions or other expenses related to such repurchases),

subject to market conditions and other factors. The actual timing, number and value of shares repurchased under the program

will be determined by management in its discretion and will depend on a number of factors, including, but not limited to, the

market price of the Common Stock and general market and economic conditions.

The Company expects to strategically and opportunistically repurchase shares from time to time through solicited or unsolicited

transactions in the open market, in privately negotiated transactions or by other means in accordance with securities laws. It is

also possible that the Company could use a portion of its share repurchase program to repurchase some of the shares of the

Company’s Common Stock held by the family of our late founder, Fred R. Adams Jr., as part of their potential portfolio

diversification. Any repurchases from the family would require special approval from a Special Committee of the Board of

Directors. The Company expects that share repurchases under the program will be funded from one or a combination of

existing cash balances and future free cash flow. The share repurchase program does not obligate the Company to repurchase

any specific amount of shares, does not have an expiration date, and may be suspended, modified or discontinued at any time

without prior notice.

Dividends

In accordance with our variable dividend policy, we will pay a cash dividend totaling approximately $169.5 million, or

approximately $3.456 per share, to holders of our Common Stock and Class A Common Stock with respect to our third quarter

of fiscal 2025. The amount paid per share will vary based on the number of outstanding shares on the record date. The dividend

is payable on May 15, 2025 to holders of record on April 30, 2025.

Material Cash Requirements

Material cash requirements for operating activities primarily consist of feed ingredients, processing, packaging and warehouse

costs, employee related costs, and other general operating expenses, which we expect to be paid from our cash from operations

and cash and investment securities on hand for at least the next 12 months. While volatile egg prices and feed ingredient costs,

among other things, make long-term predictions difficult, we have substantial liquid assets and availability under our Credit

Facility to fund future operating requirements.

Our material cash requirements for capital expenditures consist primarily of our construction projects to increase our cage-free

production capacity. We continue to monitor the increasing demand for cage-free eggs and to engage with our customers in

efforts to achieve a smooth transition toward their announced timelines for cage-free egg sales. The following table presents

material construction projects approved as of March 1, 2025 (in thousands):

Project(s) Type

Projected

Completion

Projected Cost

Spent as of March 1,

2025

Remaining

Projected Cost

Cage-Free Layer & Pullet Houses

Fiscal 2025

4,396

3,796

600

Feed Mills

Fiscal 2026

16,593

8,055

8,538

Egg Products Expansion

Fiscal 2026

20,213

7,093

13,120

Cage-Free Layer & Pullet Houses

Fiscal 2026

199,667

155,444

44,223

240,869

174,388

66,481

These projects include the addition of five new cage-free layer houses and two pullet houses across our locations in Florida,

Georgia, Utah and Texas. We expect the projects to be completed in calendar 2025 with expected additional production

capacity for approximately 1.1 million cage-free layer hens and 250 thousand pullets. We are also investing $15 million to

expand our egg products processing facility in Blackshear, Georgia to add extended shelf-life liquid eggs products.

We believe our current cash balances, investments, projected cash flows from operations, and available borrowings under our

Credit Facility will be sufficient to fund our capital expenditure cash needs for at least the next 12 months and to fund our

capital commitments currently in place thereafter.

IMPACT OF RECENTLY ISSUED/ADOPTED ACCOUNTING STANDARDS

For information on changes in accounting principles and new accounting policies, see

Note 1 - Summary of Significant

Accounting Policies

of the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.

CRITICAL ACCOUNTING ESTIMATES

Critical accounting estimates are those estimates made in accordance with U.S. generally accepted accounting principles that

involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our

financial condition or results of operations. There have been no changes to our critical accounting estimates identified in our

2024 Annual Report.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-03-01. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-12-01 to 2025-03-01$1.42bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2024-06-02 to 2025-03-01$3.16bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-12-01 to 2025-03-01$701.6mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2024-06-02 to 2025-03-01$1.84bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2024-12-01 to 2025-03-01$716.1mus-gaap:GrossProfit
Gross profit9 months2024-06-02 to 2025-03-01$1.32bnus-gaap:GrossProfit
Selling, general and administrative3 months2024-12-01 to 2025-03-01$80.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2024-06-02 to 2025-03-01$219.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-12-01 to 2025-03-01$635.7mus-gaap:OperatingIncomeLoss
Operating income9 months2024-06-02 to 2025-03-01$1.10bnus-gaap:OperatingIncomeLoss
Income tax3 months2024-12-01 to 2025-03-01$154.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-06-02 to 2025-03-01$273.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-12-01 to 2025-03-01$508.5mus-gaap:NetIncomeLoss
Net income9 months2024-06-02 to 2025-03-01$877.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-12-01 to 2025-03-01$10.38us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-06-02 to 2025-03-01$17.92us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-12-01 to 2025-03-01$10.42us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-06-02 to 2025-03-01$17.99us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-12-01 to 2025-03-0148,971,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-06-02 to 2025-03-0148,962,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-06-02 to 2025-03-01$811.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-06-02 to 2025-03-01$115.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2024-06-02 to 2025-03-01$160.8mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2025-03-01$497.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-03-01$1.98bnus-gaap:AssetsCurrent
Total assetsAt period end2025-03-01$3.08bnus-gaap:Assets
Current liabilitiesAt period end2025-03-01$513.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-03-01$694.1mus-gaap:Liabilities
Shareholders' equityAt period end2025-03-01$2.38bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001562762-25-000084. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.